Kenneth D. Nahum, MD, an oncologist and hematologist with more than four decades of experience, has been involved in dozens of drug studies in the course of his career. In addition, Dr. Kenneth D. Nahum treats cancers and blood disorders at Regional Cancer Care Associates (RCCA). Hematologists treat a wide range of blood disorders, including chronic granulomatous disease (CGD). A type of primary immunodeficiency disease (PIDD), CGD is a rare condition characterized by a faulty bone marrow gene. This gene keeps the neutrophils, or white blood cells, from producing the hydrogen peroxide needed to fight certain kinds of fungi and bacteria. As a result of their compromised immune system, people with CGD are more susceptible to fungal infections, bacterial infections, and inflammation. Most people with this condition experience at least one serious infection every three to four years. This commonly occurs in the lungs, but infection can develop elsewhere, such as in the liver or on the skin. Due to the repeated episodes of inflammation and infection, patients with CGD often have dramatically shorter life expectancies. With treatment, however, the length of life can be improved.
0 Comments
Leave a Reply. |
AuthorA practicing partner of Regional Cancer Care Associates, Dr. Kenneth D. Nahum, DO, has over 30 years of experience treating cancer patients in New Jersey and surrounding areas. Archives
March 2019
Categories |